Ignite Creation Date:
2024-05-05 @ 7:26 PM
Last Modification Date:
2024-10-26 @ 9:48 AM
Study NCT ID:
NCT00660244
Status:
COMPLETED
Last Update Posted:
2012-06-06
First Post:
2008-04-15
Brief Title:
Breast Cancer Tumor Care Observational Programme
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Breast Cancer Tumor Care Patient Observation Programme
Status:
COMPLETED
Status Verified Date:
2012-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigate efficacy and tolerability under anastrozole Arimidex treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None